PHARMACY COMPLIANCE RISK AREAS FOR 2014

Size: px
Start display at page:

Download "PHARMACY COMPLIANCE RISK AREAS FOR 2014"

Transcription

1 PHARMACY COMPLIANCE RISK AREAS FOR San Juan Puerto Rico Regional Compliance Conference Darrell W. Contreras, Esq., LHRM, CHC-F, CHPC, CHRC 5 Risk Areas 1. Overbilling of Herceptin 2. Quality and Safety of hospital-compounded pharmaceuticals B Compliance with medication eligibility 4. Medicare Part D overbilling 5. False claims resulting from improper inducements 1

2 OIG Reviews Herceptin Overbilling of multi-use vials Reviewed 665 line items totaling approx. $1.75 million. 540 line items were incorrect (81%). Overpayment of $635,000 (36%). 440 mg Herceptin/vial Providers billed for the entire vial 1unit is 10mg Medicare Claims Process Manual Chapter 17 Drugs and Biologicals Rule 70: Where HCPCS is required, units are entered in multiples of the units shown in the HCPCS narrative description. For example, if the description for the code is 50 mg, and 200 mg are provided, units are shown as 4; When the dosage amount is greater than the amount indicated for the HCPCS code, the facility rounds up to determine units. When the dosage amount is less than the amount indicated for the HCPCS code, use 1 as the unit of measure. NOTE: Multi-use vials are not subject to payment for discarded amounts of drug or biological. (Section 40) 2

3 Example 1: HCPCS Drug Dosage J9355 Trastuzumab 10 mg Actual Dose: 140 mg Number of Units billed = Example 2: HCPCS Drug Dosage J3100 Tenecteplase 50 mg Actual Dose: 40 mg Number of Units billed = 3

4 Example 3: HCPCS Drug Dosage J9355 Trastuzumab 10 mg Actual Dose: 150 mg Vial Size: 440 mg Number of Units billed = 44 Correct Number of Units = OIG Herceptin Review Lessons Learned: Review your Herceptin billing What is the process to calculate units billed? Periodically review the reporting of billable units Check the math Understand different reporting methodologies Billing guidelines vary for different usage types 4

5 Compounding Pharmacies 2012 NECC Meningitis Outbreak Contaminated injections National attention Patients died Raised concern about documentation and quality of compounding State attention: Quality and documentation requirements added Federal attention: OIG Workplan OIG Workplan Oversight of pharmaceutical compounding (new) Quality of Care and Safety. We will describe Medicare s oversight of pharmaceutical compounding in Medicareparticipating acute care hospitals. We will also describe how State agencies and hospital accreditors assess such pharmacy services in hospitals. 5

6 State Boards of Pharmacy New Regulations Documentation of each compounding step. Audit trail for at least 2 years Pharmacist oversight Documented process What to Look For: Tracking adverse drug reactions to med prep Tracking quality measures within pharmacy 340B Compliance Audits HRSA oversees contract pharmacy arrangements in the 340B Program OIG Workplan: Tracking of drug sales Only eligible participants can receive 340B drugs. Duplicate discounts No payment of Medicaid rebates for 340B drugs Access to 340B ceiling prices Covered entity access to assess pricing (Required by ACA 7102) Drug manufacturer overcharges 6

7 340B Audits OPA requirements for 340B compliance (Feb 5, 2014): Conduct independent annual audits or implement an adequate mechanism for oversight of contract pharmacy arrangements; Maintain auditable records, compliant agreements with contract pharmacies and written policies and procedures related to contract pharmacy oversight; Ensure that 340B drugs are delivered only to eligible patients; "Carve out" Medicaid or develop an alternative arrangement with the state Medicaid agency to prevent duplicate discounts; and Maintain accurate information, including contract pharmacy information, in the HRSA 340B database. 340B Audits Lessons Learned: 1. Have a good 340B compliance program in place and audit recipient eligibility 2. Review the controls to prevent duplicate discounts 3. Check manufacturer pricing 7

8 Medicare Part D Billing fraud May 2012 OIG Report on Retail pharmacies 2637 participating pharmacies with questionable billing practices Issues: Billing for nonexistent prescriptions; Billing for brand name drugs when generic is dispensed; Billing for prescriptions that were not picked up. Medicare Part D Billing fraud Markers: Amounts billed per beneficiary Number of prescriptions per beneficiary Amounts billed per prescriber Number of prescriptions per prescriber Percentage of prescriptions for Schedule II drugs Percentage of prescriptions for Schedule III drugs Percentage of prescriptions for brand-name drugs Percentage of prescriptions that are refills, to identify pharmacies exhibiting aberrant billing patterns. 8

9 Medicare Part D Billing fraud Lesson Learned: 1. Periodic audit to match bills to prescriptions 2. Match billed medication to prescribed medication 3. Ensure pick-up is documented 4. Review the markers! Medicare False Billing Case Walgreens (April 20, 2012) $25 gift cards given to beneficiaries who transferred prescriptions to Walgreens from another pharmacy Excluded government health care programs Walgreens employees ignored exemptions and provided gift cards to all beneficiaries 9

10 Medicare False Billing Case False Billing? Impermissible inducement to federal health care program beneficiaries All claims that are submitted as a result of the inducement are false claims Result: $7.9 Million settlement Medicare False Billing Case Lesson Learned: Review all benefit programs to beneficiaries Ensure proper controls are in place Always ask, What if? 10

11 Questions? Darrell W. Contreras, Esq., LHRM, CHC-F, CHPC, CHRC Partner Phone: (863)

THE LATEST ON THE 340B FRONT

THE LATEST ON THE 340B FRONT September 1, 2015 Connie Ouellette, Principal Carole Barker, Senior Consultant THE LATEST ON THE 340B FRONT berrydunn.com AGENDA Mega Guidance released! Audit update from HRSA Maintaining compliance Areas

More information

11/12/2015 THE LATEST ON THE 340B FRONT AGENDA MEGA GUIDANCE RELEASED. Mega Guidance released. Audit update from HRSA. Maintaining compliance

11/12/2015 THE LATEST ON THE 340B FRONT AGENDA MEGA GUIDANCE RELEASED. Mega Guidance released. Audit update from HRSA. Maintaining compliance November 19, 2015 Connie Ouellette, Principal Carole Barker, Senior Consultant THE LATEST ON THE 340B FRONT berrydunn.com AGENDA Mega Guidance released Audit update from HRSA Maintaining compliance Areas

More information

Market Distortions from the 340B Drug Pricing Program

Market Distortions from the 340B Drug Pricing Program Market Distortions from the 340B Drug Pricing Program Adam J. Fein, Ph.D. www.drugchannels.net @DrugChannels The opinions and views expressed in this presentation are those of the author and may not reflect

More information

In its written comments on our draft report, CMS concurred with our recommendation.

In its written comments on our draft report, CMS concurred with our recommendation. Page 2 Kerry Weems We recommend that Congress and CMS consider the results our review, including the data provided, in any deliberations regarding Medicare Part D reimbursement. In its written comments

More information

Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010

Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010 Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010 Physician-Administered Drugs Physician-administered drugs are drugs, other than vaccines,

More information

Physician s Compliance Guide

Physician s Compliance Guide Physician s Compliance Guide Updates to this guide will be posted on the Optum website and can be found at: http://www.optumcoding.com/product/updates/2013pcg/pcg13 Please use the following password to

More information

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Speaker Brian K. Solow, MD, FAAFP Optum Life Sciences Irvine, CA, USA PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Brian K. Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences

More information

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being

More information

The Value of Walgreens

The Value of Walgreens The Value of Walgreens How Walgreens improves employer health plans through access, quality and lower costs Why millions of patients choose Walgreens And your options to move forward with Walgreens Walgreens

More information

Tracking, Trending and Auditing Across a Multi-State Health System

Tracking, Trending and Auditing Across a Multi-State Health System Tracking, Trending and Auditing Across a Multi-State Health System Fifth National Medicare RAC Summit March 10, 2011 Susan Shiflett, RHIA, CHC Director Corporate Responsibility Catholic Health Initiatives

More information

Questionable Billing and Geographic Hotspots Point to Potential Fraud and Abuse in Medicare Part D

Questionable Billing and Geographic Hotspots Point to Potential Fraud and Abuse in Medicare Part D HHS OIG Data Brief June 2015 OEI-02-15-00190 Questionable Billing and Geographic Hotspots Point to Potential Fraud and Abuse in Medicare Part D Key Takeaways: Since 2006, Medicare spending for commonly

More information

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS For Producer Audience Only - Please Do Not Distribute Regence has selected Prime Therapeutics as the Pharmacy benefits manager for its health plans.

More information

Report to the Social Services Appropriations Subcommittee

Report to the Social Services Appropriations Subcommittee Report to the Social Services Appropriations Subcommittee Medicaid Coverage and Reimbursement for Outpatient Physical Therapy and Outpatient Occupational Therapy Prepared by the Division of Medicaid and

More information

Changes to the Eighth Edition

Changes to the Eighth Edition Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,

More information

General Providers. Tamper-Resistant Prescription Requirements

General Providers. Tamper-Resistant Prescription Requirements September 2008 Provider Bulletin Number 8138 General Providers Tamper-Resistant Prescription Requirements Effective with processing dates on and after October 1, 2008, written prescriptions for Kansas

More information

Curbing Prescription Drug Abuse in Medicaid

Curbing Prescription Drug Abuse in Medicaid Curbing Prescription Drug Abuse in Medicaid Joint Legislative Health Care Oversight Committee October 12, 2010 Dr. Lisa Weeks, BSPharm, PharmD Pharmacy and Ancillary Services Division of Medical Assistance

More information

Legislative & Regulatory Update Brad Young, RxPlus Government Affairs

Legislative & Regulatory Update Brad Young, RxPlus Government Affairs Legislative & Regulatory Update 2018 Brad Young, RxPlus Government Affairs Disclosures Brad Young reports no actual or potential conflicts of interest associated with this presentation. 2 Learning Objectives

More information

Medicaid Reimbursement for Tobacco Cessation Quitline Activities

Medicaid Reimbursement for Tobacco Cessation Quitline Activities Medicaid Reimbursement for Tobacco Cessation Quitline Activities Sharon Brown Financial Management Group (FMG) Center for Medicaid, CHIP and Survey & Certification (CMCS) 1 CMS issued a State Medicaid

More information

New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.

New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved. New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program 1 About Express Scripts Express Scripts is RHCA s chosen partner for administering your prescription plan We are a leading

More information

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription

More information

DIABETES TEST STRIPS REIMBURSEMENT REDUCTIONS TO INDEPENDENT PHARMACIES WILL NEGATIVELY IMPACT MEDICARE PATIENTS

DIABETES TEST STRIPS REIMBURSEMENT REDUCTIONS TO INDEPENDENT PHARMACIES WILL NEGATIVELY IMPACT MEDICARE PATIENTS DIABETES TEST STRIPS REIMBURSEMENT REDUCTIONS TO INDEPENDENT PHARMACIES WILL NEGATIVELY IMPACT MEDICARE PATIENTS NCPA Member Survey Results September 2012 CMS is considering cutting payments to pharmacies

More information

ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans

ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans DEPARTMENT: Medicare Compliance POLICY TITLE: RELATED DEPARTMENTS: All POLICY #: 706 C VERSION #: 4 REVISION DATE: Identifying

More information

July 30, VIA TO

July 30, VIA  TO July 30, 2012 VIA EMAIL TO DMEPOS@cms.hhs.gov Elliot Klein Centers for Medicare and Medicaid Services 7500 Security Boulevard Mail Stop C5-03-17 Baltimore, MD 21244-1850 RE: Inherent Reasonableness of

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on:

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on: Statement Of The National Association of Chain Drug Stores For U.S. Senate Committee on Finance Hearing on: 10:00 a.m. National Association of Chain Drug Stores (NACDS) 1776 Wilson Blvd., Suite 200 Arlington,

More information

PHYSICIAN ENGAGEMENT IN THE COMPLIANCE PROCESS

PHYSICIAN ENGAGEMENT IN THE COMPLIANCE PROCESS PHYSICIAN ENGAGEMENT IN THE COMPLIANCE PROCESS R. Brett Short, CHC, CHPC, Chief Compliance Officer, UK HealthCare Sarah Couture, RN, CHC, Associate, Aegis Compliance and Ethics The Power of Advanced Medicine

More information

U.S. Department of Health and Human Services Office of Inspector General. An OIG Portfolio A

U.S. Department of Health and Human Services Office of Inspector General. An OIG Portfolio A U.S. Department of Health and Human Services Office of Inspector General MEDICARE NEEDS BETTER CONTROLS TO PREVENT FRAUD, WASTE, AND ABUSE RELATED TO CHIROPRACTIC SERVICES February 2018 An OIG Portfolio

More information

October 27, Re: 340B Drug Pricing Omnibus Guidance (RIN 0906-AB08) Dear Captain Pedley:

October 27, Re: 340B Drug Pricing Omnibus Guidance (RIN 0906-AB08) Dear Captain Pedley: October 27, 2015 Krista Pedley, Director Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) 5600 Fishers Lane Mail Stop 08W05A Rockville, Maryland 20857 (submitted electronically)

More information

Legislative and Regulatory Update Michael Baxter APhA Director, Regulatory Affairs

Legislative and Regulatory Update Michael Baxter APhA Director, Regulatory Affairs Legislative and Regulatory Update 2018 Michael Baxter APhA Director, Regulatory Affairs 1 CPE Information and Disclosures Michael Baxter declares no conflicts of interest, real or apparent, and no financial

More information

CERT Oxygen Errors: The DME CERT Outreach and Education Task Force Responds

CERT Oxygen Errors: The DME CERT Outreach and Education Task Force Responds CERT Oxygen Errors: The DME CERT Outreach and Education Task Force Responds DME CERT Outreach and Education Task Force National Oxygen Webinar, July 22, 2014 1 Today s Presenters Michael Hanna, CERT Task

More information

What s New. Don t Forget! There are 2 different influenza vaccines available. Flu Vaccine. Michigan Newsletter Fall 2009

What s New. Don t Forget! There are 2 different influenza vaccines available. Flu Vaccine. Michigan Newsletter Fall 2009 What s New Michigan Newsletter Fall 2009 Flu Vaccine Don t Forget! There are 2 different influenza vaccines available this year (one for seasonal flu and one for Novel H1N1 or swine flu). Both vaccines

More information

CBR201609: Diabetic Testing Supplies

CBR201609: Diabetic Testing Supplies Stay Tuned for Webinar Audio dial-in: 323 920 0091; PIN: 256-7691# For technical assistance, send email to support@anymeeting.com : Diabetic Testing Supplies 3:00 P.M. ET July 27, 2016 : Diabetic Testing

More information

STATE OF NEW JERSEY OFFICE OF THE STATE COMPTROLLER MEDICAID FRAUD DIVISION

STATE OF NEW JERSEY OFFICE OF THE STATE COMPTROLLER MEDICAID FRAUD DIVISION STATE OF NEW JERSEY OFFICE OF THE STATE COMPTROLLER MEDICAID FRAUD DIVISION COMPLIANCE AUDIT REVIEW OF SUBOXONE FINAL AUDIT REPORT A. Matthew Boxer September 25, 2013 COMPTROLLER Executive Summary As part

More information

FlexRx 6-Tier. SM Pharmacy Benefit Guide

FlexRx 6-Tier. SM Pharmacy Benefit Guide FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many

More information

Monitoring the Accuracy of Hospital Coding (OEI )

Monitoring the Accuracy of Hospital Coding (OEI ) DATE: January 21, 1999 FROM: SUBJECT: TO: June Gibbs Brown Inspector General Monitoring the Accuracy of Hospital Coding (OEI-01-98-00420) Nancy-Ann Min DeParle Administrator Health Care Financing Administration

More information

Risk Classification Modeling to Combat Opioid Abuse

Risk Classification Modeling to Combat Opioid Abuse Risk Classification Modeling to Combat Opioid Abuse Improve Data Sharing to Identify High-Risk Prescribers of Opioids Christopher Sterling Chief Statistician NCI, Inc. www.nciinc.com 11730 Plaza America

More information

Crowe Healthcare Webinar Series

Crowe Healthcare Webinar Series Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President

More information

Overview. Provider Enrollment Requirements Member Eligibility Hearing Services Authorization and Billing Additional Information

Overview. Provider Enrollment Requirements Member Eligibility Hearing Services Authorization and Billing Additional Information Audiology Services Overview Provider Enrollment Requirements Member Eligibility Hearing Services Authorization and Billing Additional Information 2 Provider Enrollment 3 Alaska Medicaid Provider Enrollment

More information

Medicare Physical Therapy Billing Guidelines 2012

Medicare Physical Therapy Billing Guidelines 2012 Medicare Physical Therapy Billing Guidelines 2012 Important Notice! A random sample of APTA members will soon be selected to respond to a survey about new physical therapy evaluation and reevaluation CPT.

More information

a guide to Reimbursement of Intermittent Catheters Know your options M2116N 04.08

a guide to Reimbursement of Intermittent Catheters Know your options M2116N 04.08 a guide to Reimbursement of Intermittent Catheters 1 Know your options Coloplast Corp. Minneapolis, MN 55411 1.800.533.0464 usmedweb@coloplast.com www.us.coloplast.com is a registered trademark of Coloplast

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget. Statement Of The National Association of Chain Drug Stores For U.S. House of Representatives Committee on the Budget Hearing on: 2:00 p.m. 210 Cannon House Office Building National Association of Chain

More information

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Texas Vendor Drug Program Specialty Drug List Process. February 2019 Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed

More information

Round 2 DME Competitive Bidding Program

Round 2 DME Competitive Bidding Program Round 2 DME Competitive Bidding Program Presented by Diane Caradeuc CMS-SMP Liaison This Senior Medicare Patrol educational effort is supported and funded by the Administration on Aging. DMEPOS Categories

More information

Value of Hospice Benefit to Medicaid Programs

Value of Hospice Benefit to Medicaid Programs One Pennsylvania Plaza, 38 th Floor New York, NY 10119 Tel 212-279-7166 Fax 212-629-5657 www.milliman.com Value of Hospice Benefit May 2, 2003 Milliman USA, Inc. New York, NY Kate Fitch, RN, MEd, MA Bruce

More information

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)

More information

Billing & Coding Guide

Billing & Coding Guide Billing & Coding Guide CMS established a unique J-code to facilitate reimbursement of ENVARSUS XR J7503 Suggested Coding and Medicare Allowables Coding Overview and Payment Rates Used to Report Code Description

More information

Managed Care Pushes for Safer Opioid Oversight

Managed Care Pushes for Safer Opioid Oversight Page 1 of 6 Clinical AUGUST 11, 2017 Managed Care Pushes for Safer Opioid Oversight High-risk pain Rx eyed Denver Health systems haven t escaped the nation s ongoing opioid crisis, as evidenced by surging

More information

Issues for Part D Compliance

Issues for Part D Compliance HCCA- MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE Issues for Part D Compliance Craig Miner, RPh, JD Division of Drug Plan Policy Babette S. Edgar, Pharm.D., MBA Division of Finance and Operations

More information

Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study

Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois

More information

ALLERGY TESTING AND ALLERGY IMMUNOTHERAPY

ALLERGY TESTING AND ALLERGY IMMUNOTHERAPY ALLERGY TESTING AND ALLERGY IMMUNOTHERAPY Policy Neighborhood Health Plan reimburses contracted providers for the provision of medically necessary clinically indicated allergy testing and allergy immunotherapy

More information

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended

More information

SECTION PRESCRIPTIONS

SECTION PRESCRIPTIONS SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or

More information

Do not open the test booklet prior to being told to do so.

Do not open the test booklet prior to being told to do so. Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources

More information

32 CFR (a)(4), (a)(6)(iii), and (a)(6)(iv)

32 CFR (a)(4), (a)(6)(iii), and (a)(6)(iv) CHAPTER 15 SECTION 1 ISSUE DATE: November 6, 2007 AUTHORITY: 32 CFR 199.14(a)(4), (a)(6)(iii), and (a)(6)(iv) I. APPLICABILITY This policy is mandatory for the reimbursement of services provided either

More information

NCPA LTC Division Newsletter

NCPA LTC Division Newsletter March 2016 NCPA LTC Division Newsletter NCPA Offers FDA Additional Information on Repackaging Draft Guidance NCPA recently joined with the American Society of Consultant Pharmacists (ASCP) in a follow

More information

RETIRED. Maximum Drug Dose Policy

RETIRED. Maximum Drug Dose Policy RETIRED DRUG POLICY Policy Number 2017D0034A Maximum Drug Dose Policy Annual Approval Date 3/1/2017 Approved By UnitedHealthcare National Pharmacy & Therapeutics Committee United Healthcare Community Plan

More information

ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans

ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans DEPARTMENT: Medicare Compliance POLICY TITLE: RELATED DEPARTMENTS: All POLICY #: 700C VERSION #: 3 REVISION DATE: Medicare

More information

Overview. Ontario Public Drug Programs, Ministry of Health and Long-Term Care

Overview. Ontario Public Drug Programs, Ministry of Health and Long-Term Care Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2015 Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims

More information

VA Walgreens Collaboration

VA Walgreens Collaboration VA Walgreens Collaboration Harry Leider, Chief Medical Officer Jim Wood, Vice President Federal December 15, 2015 Overview Walgreens Background VA / Walgreens Relationship VA Immunization Program IT Architecture

More information

1. When are dispensers able to provide publicly funded naloxone emergency kits for Ontarians?

1. When are dispensers able to provide publicly funded naloxone emergency kits for Ontarians? Ontario Public Drug Programs Division Ontario Naloxone Program for Pharmacies (ONPP) Frequently Asked Questions for Pharmacy Dispensers: Providing Publicly Funded Naloxone Kits and Claims Submission Using

More information

Part D PDE Data and the Opioid Epidemic

Part D PDE Data and the Opioid Epidemic Part D PDE Data and the Opioid Epidemic State Data Resource Center Acumen, LLC August 30, 2017 3:30-4:30pm ET Outline Background Information on Opioid Use Helpful Part D Elements for Analysis How to Perform

More information

This Frequently Asked Questions document contains various aspects of UIIP in the following sections. Overview Eligibility...

This Frequently Asked Questions document contains various aspects of UIIP in the following sections. Overview Eligibility... Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2017: Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims

More information

BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director

BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director BOARD OF PHARMACY- REGULATORY UPDATE Kimberly Grinston, J.D., Executive Director Disclosure and Conflict of Interest I declare no conflicts of interest, real or apparent, and no financial interest in any

More information

Pharmaceutical Management Medicaid 2019

Pharmaceutical Management Medicaid 2019 Pharmaceutical Management Medicaid 2019 Toll-free Contact Number: (888) 327-0671 Pharmacy Administration: (810) 244-1660 Introduction Pharmaceutical Management promotes the use of the most clinically appropriate,

More information

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. Arizona Corporate Counsel Presentation May 8, 2018 Agenda 1. Overview of the Opioid

More information

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List Overview The management of outpatient prescription drugs is an integral part of the medical management program to improve the health and well-being of our members. Prescriber and member involvement is

More information

VIA ELECTRONIC SUBMISSION: September 10, 2018

VIA ELECTRONIC SUBMISSION:   September 10, 2018 VIA ELECTRONIC SUBMISSION: http://www.regulations.gov Seema Verma Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1691-P 7500 Security Boulevard

More information

CERT PAP Errors: The DME CERT Outreach and Education Task Force Responds

CERT PAP Errors: The DME CERT Outreach and Education Task Force Responds CERT PAP Errors: The DME CERT Outreach and Education Task Force Responds DME CERT Outreach and Education Task Force National PAP Webinar, December 17, 2014 PAP CERT Errors Medical Records: Face-to-Face

More information

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care 203 - Monday, April 16, 2018 Today s Presenters Ben Purser Former F.B.I. Special Agent Donna Thiel ProviderTrust Chief

More information

FRAUD PREVENTION IN MEDICAID. Dr. SERPIL TOKDEMIR YUCE, Ph.D. Office of Medicaid Inspector General Arkansas State USA

FRAUD PREVENTION IN MEDICAID. Dr. SERPIL TOKDEMIR YUCE, Ph.D. Office of Medicaid Inspector General Arkansas State USA FRAUD PREVENTION IN MEDICAID Dr. SERPIL TOKDEMIR YUCE, Ph.D. Office of Medicaid Inspector General Arkansas State USA Mission of OMIG To detect and prevent fraud, waste, and abuse within the medical

More information

Pharmacy Audit Recovery Guidelines

Pharmacy Audit Recovery Guidelines 1/1E DAW 1 DAW 1 Error The prescription order does not indicate the prescriber ordered brand name. 2 /2E DAW 2 DAW 2 Not Documented The documentation does not specify the patient s request for brand. Pharmacy

More information

Agency Report Item 11: Oregon Health Authority Meningitis Vaccination Program in Lane County

Agency Report Item 11: Oregon Health Authority Meningitis Vaccination Program in Lane County Agency Report Item 11: Oregon Health Authority Meningitis Vaccination Program in Lane County Analyst: Linda Ames Request: Acknowledge receipt of a report on the meningitis vaccination program in Lane County.

More information

Medicare Part D Opioid Policies for 2019 Information for Patients

Medicare Part D Opioid Policies for 2019 Information for Patients CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Opioid Policies for 2019 Information for Patients Introduction Prescription opioid pain medications like oxycodone (OxyContin ), hydrocodone (Vicodin

More information

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments VIA Electronic Submission to http://www.regulations.gov September 29, 2009 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Docket

More information

Mail Service Pharmacy

Mail Service Pharmacy Mail Service s At A Glance Disclaimer: reserves the right to update its measures and measure sets to maintain measure relevancy and to remedy any unintended consequences that may arise during implementation.

More information

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI Case 4:08-cv-01915-TCM Document 48 Filed 04/28/2009 Page 1 of 12 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EXPRESS SCRIPTS, INC., ) ) Plaintiff, ) ) vs. ) Cause No.: 4:08-cv-1915 ) WALGREEN

More information

For the 2017/2018 Influenza Immunization Season. Patient Eligibility. Description. Ontario Public Drug Programs, Ministry of Health and Long-Term Care

For the 2017/2018 Influenza Immunization Season. Patient Eligibility. Description. Ontario Public Drug Programs, Ministry of Health and Long-Term Care Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Pharmacist Administration of Publicly Funded Influenza Vaccines and Claims Submission using the Health

More information

2009 Pain Coding Update and Pain Industry Business Trends

2009 Pain Coding Update and Pain Industry Business Trends 2009 Pain Coding Update and Pain Industry Business Trends Linda Van Horn, MBA June 13, 2009 2009 Pain Coding Update and Pain Industry Trends Agenda 2009 CPT Coding Updates Pay For Incentives ICD-10 American

More information

Amy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group

Amy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 CENTER FOR MEDICARE TO: FROM: SUBJECT: All Part D Sponsors Amy Larrick

More information

- Description, Objectives, Operational Framework

- Description, Objectives, Operational Framework 2 1. CNCD - Overview (significance, causes, burden) 2. CDAP - Description, Objectives, Operational Framework 3. Research Findings of Study on CDAP - Research Objectives and Methodology - Limitations and

More information

FREE STATEWIDE PRESCRIPTION ASSISTANCE PROGRAM

FREE STATEWIDE PRESCRIPTION ASSISTANCE PROGRAM FREE STATEWIDE PRESCRIPTION ASSISTANCE PROGRAM FLORIDA RX CARD Free statewide prescription assistance program Available to everyone in the state regardless of residency, immigration, or citizenship status

More information

Pharmacy benefit guide

Pharmacy benefit guide FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications

More information

Washington State Medicaid Prescription Drug Purchasing: Preferred Drug List

Washington State Medicaid Prescription Drug Purchasing: Preferred Drug List Washington tate Medicaid Prescription rug Purchasing: Preferred rug List NLPE Conference eptember 21, 2011 John Bowden Joint Legislative udit & eview Committee JLC Background he Joint Legislative udit

More information

Ontario Public Drug Programs, Ministry of Health and Long-Term Care. For the Influenza Immunization Season

Ontario Public Drug Programs, Ministry of Health and Long-Term Care. For the Influenza Immunization Season Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Pharmacist Administration of Publicly Funded Influenza Vaccines and Claims Submission using the Health

More information

The Oncology Drug Marketplace: Trends in Discounting and Site of Care

The Oncology Drug Marketplace: Trends in Discounting and Site of Care The Oncology Drug Marketplace: Trends in Discounting and Site of Care DECEMBER 2017 PREPARED BY: Aaron Vandervelde avandervelde@thinkbrg.com 202.480.2661 Eleanor Blalock eblalock@thinkbrg.com 202.480.2772

More information

Partial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report. User s Guide Sixth Edition. Prepared by

Partial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report. User s Guide Sixth Edition. Prepared by Partial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report User s Guide Sixth Edition Prepared by Partial Hospitalization Program Program for Evaluating Payment Patterns

More information

Sub. S.B. 119 As Passed by the Senate

Sub. S.B. 119 As Passed by the Senate AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,

More information

Medicare Advantage Outreach and Education Bulletin

Medicare Advantage Outreach and Education Bulletin Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain

More information

Standards, Education, Verification. Patient Focused Certification

Standards, Education, Verification. Patient Focused Certification Standards, Education, Verification Patient Focused Certification PFC Training helps you achieve quality standards. Staff Certification is now available online www.pfctraining.org jahan@safeaccessnow.org

More information

Analysis Item 13: Oregon Health Authority Meningitis Vaccination Program

Analysis Item 13: Oregon Health Authority Meningitis Vaccination Program Analysis Item 13: Oregon Health Authority Meningitis Vaccination Program Analyst: Linda Ames Request: Acknowledge receipt of a report on the meningitis vaccination program in Lane County. Recommendation:

More information

Chapter 18 Section 15. Department Of Defense (DoD) Applied Behavior Analysis (ABA) Pilot For Non-Active Duty Family Members (NADFMs)

Chapter 18 Section 15. Department Of Defense (DoD) Applied Behavior Analysis (ABA) Pilot For Non-Active Duty Family Members (NADFMs) Demonstrations And Pilot Projects Chapter 18 Section 15 Department Of Defense (DoD) Applied Behavior Analysis (ABA) Pilot 1.0 PURPOSE Under authority of 10 United States Code (USC) 1092, TRICARE will continue

More information

Medicare STRIDE SM Physician Quality Program 2019 Program Overview

Medicare STRIDE SM Physician Quality Program 2019 Program Overview Medicare STRIDE SM Quality Program 2019 Program Overview Health Services- Managed by Network Medical Management 2019 Program 1 Medicare Advantage Quality Program Program Overview The Plan will support

More information

The Age of Audits. The Age of Audits Optometry has never been targeted has that changed? What would you do??? The Age of Audits DISCLAIMER

The Age of Audits. The Age of Audits Optometry has never been targeted has that changed? What would you do??? The Age of Audits DISCLAIMER Is this the Golden Age of audits? Joe W DeLoach, OD, FAAO CEO, Optometric Business Solutions Optometry has never been targeted has that changed? If you are filing claims, you are a target! DISCLAIMER I

More information

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists Background Opioid medications are effective at treating certain types of pain,

More information

Substitute HB 523 Outline

Substitute HB 523 Outline Substitute HB 523 Outline 1. Creates Medical Marijuana Control Commission under the auspice of the Department of Commerce 9 member commission No more than 4 members of the Commission shall be from 1 political

More information

A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)

A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP) A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP) May 2014 RubiReview Program Overview... 3 Overview... 3 Adherence Packaging (RubiPaks)... 4 Eligibility... 4 Financial

More information

2

2 1 2 3 4 5 6 7 8 9 ADAP client enrollment and client utilization reached their highest levels during FY2010. However, as a result of the national fiscal crisis and implementation of cost-containment measures,

More information

340B Audit Experiences from 2015: What We Learned From Over 50 Audits

340B Audit Experiences from 2015: What We Learned From Over 50 Audits 340B Audit Experiences from 2015: What We Learned From Over 50 Audits ROB NAHOOPII, PHARMD, MS, BCPS RICH BUCHER, JD, RPH TURNKEY PHARMACY SOLUTIONS Statement of Conflicts of Interest Rob Nahoopii Rich

More information

Chapter 15 Section 1

Chapter 15 Section 1 Chapter 15 Section 1 Issue Date: November 6, 2007 Authority: 32 CFR 199.14(a)(3) and (a)(6)(ii) 1.0 APPLICABILITY This policy is mandatory for the reimbursement of services provided either by network or

More information

NEW PROVIDER ENROLLMENT FOR ADULT SITE

NEW PROVIDER ENROLLMENT FOR ADULT SITE New Jersey Department of Health Vaccines for Children (NJVFC) Program P.O. Box 369 Trenton, NJ 08625-0369 Phone: (609) 826-4862 Fax: (609) 826-4868 INSTRUCTIONS: Email completed New Provider Enrollment

More information